Insmed Inc (INSM)vsPasithea Therapeutics Corp (KTTA)
INSM
Insmed Inc
$136.00
-5.56%
HEALTHCARE · Cap: $29.32B
KTTA
Pasithea Therapeutics Corp
$0.77
-3.39%
HEALTHCARE · Cap: $25.09M
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 124535% more annual revenue ($606.42M vs $486,560). KTTA leads profitability with a 0.0% profit margin vs -210.5%. INSM earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
KTTA
Avoid33
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 152.6% year-over-year
Reasonable price relative to book value
Revenue surging 1498.0% year-over-year
Areas to Watch
0.0% earnings growth
Trading at 39.4x book value
ROE of -249.3% — below average capital efficiency
Negative free cash flow — burning cash
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
The strongest argument for INSM centers on Revenue Growth. Revenue growth of 152.6% demonstrates continued momentum. PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : KTTA
The strongest argument for KTTA centers on Price/Book, Revenue Growth. Revenue growth of 1498.0% demonstrates continued momentum.
Bear Case : INSM
The primary concerns for INSM are EPS Growth, Price/Book, Return on Equity.
Bear Case : KTTA
The primary concerns for KTTA are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
KTTA is growing revenue faster at 1498.0% — sustainability is the question.
KTTA generates stronger free cash flow (-3M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
INSM scores higher overall (39/100 vs 33/100) and 152.6% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Pasithea Therapeutics Corp
HEALTHCARE · BIOTECHNOLOGY · USA
Pasithea Therapeutics Corp. The company is headquartered in Miami Beach, Florida.
Visit Website →Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?